|
|
Clinuvel Pharmaceuticals Ltd ADR
NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/25/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization291.47 mln
Float43.88 mln
Earnings Date02/23/2027
Relative Strength
20
/ 100
Significantly lagging
Key Fundamentals
EPS0.48
P/E11.73
ROE13.81
ROIC98.81
ROA12.55
Interest Cover8.53
EBITDA, mln32.99
EV / EBITDA3.86
EV / EBIT3.95
Revenue, mln63.19
EV / Revenue2.02
Quote Details
Last
5.63
Change
-0.15 (-2.6%)
Open
5.82
Volume
13,131
Turnover
73,928
Average Volume
26,180
Financial Ratios
Pre-Tax Profit Margin46
Current Ratio14.64
Price / Book1.71
Price / Tangible Book1.71
Price / Free Cash Flow10.68
Debt / Equity0.01
Price / Sales4.44
PEG Ratio0.42
Financial Strength
Altman Z-Score10.68
Piotroski F-Score
6
/ 9
Beneish M-Score-2.46
Price to Intrinsic Value0.70
Price to Lynch Fair Value0.47
Price to Graham Number1.00
Shiller PE Ratio19.37
Short Ratio1.04
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-4.58% |
15
/ 100
 |
| 1 Month |
-25.92% |
7
/ 100
 |
|
| |
